Senior insider sale
SYROS PHARMACEUTICALS, INC. — senior position signals high conviction
$2.0K
9.33K shares
What this filing means
WIRTH PETER plans to sell 9.33K shares of SYROS PHARMACEUTICALS, INC. valued at approximately $2.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/11/2025ACC: 0001972362-25-000274
9.33K
Shares to sell
$2.0K
Approx. market value
9.33K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
RESTRICTED STOCK
COMPENSATION
9/16/2024
2.67KRESTRICTED STOCK
COMPENSATION
6/1/2024
4KRESTRICTED STOCK
COMPENSATION
9/16/2023
2.67KTotal acquired9.33K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/16/2024 | RESTRICTED STOCK COMPENSATION | 2.67K | — |
6/1/2024 | RESTRICTED STOCK COMPENSATION | 4K | — |
9/16/2023 | RESTRICTED STOCK COMPENSATION | 2.67K | — |
| Total | 9.33K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
9.33K
Market value
$2.0K
3/11/2025
Total
Units
9.33K
Value
$2.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/11/2025 | 9.33K | $2.0K | NASDAQ | Planned |
| Total | 9.33K | $2.0K | ||